Written answers

Tuesday, 29 January 2019

Department of Health

Medicinal Products Reimbursement

Photo of Denis NaughtenDenis Naughten (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source

441. To ask the Minister for Health the reason pioglitazone remains an approved drug under the GMS for the treatment of diabetes in view of the fact that the US Food and Drug Administration has found it to be associated with bladder tumours; and if he will make a statement on the matter. [4367/19]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.